JPS623158Y2 - - Google Patents

Description

[Detailed Description of the Invention] The present invention relates to an indeterminate complaint treatment member comprising a diode, a magnet, and a specific drug.

In recent years, a therapy has been proposed in which a diode is pasted on the skin and the rectifying action or electromotive force of the diode is used to treat indefinite complaints (for example, Ido no Nippon, published by Ido, No. 421, No. 422, No. 426, 428, 432, etc.).

By the way, the present inventors have conducted various studies on this diode therapy, and have found that a synergistic effect can be obtained for the treatment of indefinite complaints by using a diode, a magnet, a skin irritating drug, and an analgesic and anti-inflammatory drug together. They discovered this and completed the present invention after further research.

That is, in the present invention, a conductive layer is provided approximately at the center of a magnetic adhesive sheet, either directly or via a carrier, a spacer, and/or an adhesive, leaving a gap, and a diode with lead wires at both ends is provided in the gap. is installed, and a diode with lead wires at both ends is covered and fixed with the conductive layer at the lead wire portion without damaging the skin, and at least the conductive layer and/or the adhesive of the magnetic adhesive sheet contains a skin irritating drug. and analgesic and anti-inflammatory agents.

As the diode used in the present invention, any diode conventionally used for diode therapy can be used, and for example, diode for rectification, high frequency detection, constant voltage, etc. can also be used.
Specifically, those made of germanium, silicon, germanium-gallium, etc. are enumerated.

The analgesic and anti-inflammatory agents used in this invention include steroidal anti-inflammatory analgesics such as hydrocortisone acetate and fluorocinolone acetonide, and non-steroidal analgesics and anti-inflammatory agents such as indomethacin, flurbipfen, glycyrrhizin, allantoin, methyl salicylate, and monoglycol salicylate. Medicines can be given. In addition, skin irritants include hot-sensitive drugs such as hot pepper extract, capsaicin, nonylic acid vanillylamide, β-butoxyethyl nicotinate, cantharis tincture, cantharidin, l-menthol, dl- or d-camphor, borneol, pepper oil, etc. Examples include cold-sensitive drugs.

Hereinafter, specific examples of the treatment member of the present invention will be explained using the drawings.

In FIGS. 1A and B, 1 is a magnetic adhesive sheet, which includes, for example, a magnetic sheet 11 made of a rubber resin or the like mixed with a magnetic material such as Baryuferite, and an adhesive layer which may contain a drug. 1
It consists of 2. 2 is the diode body,
3 and 3' are lead wires. Reference numerals 4 and 4' are conductive layers that may contain drugs, and the layers 4 and 4' generally include rubber and/or synthetic resins, conductive powder (such as carbon, metal powder, etc.), and, if necessary, It is composed of a composition containing a drug. The layers 4, 4' are formed by leaving a gap approximately in the center of the magnetic adhesive sheet 1 (for example, adhesive,
(by adhesive means such as welding). The diode main body 2 is installed in the gap, and the lead wires 3 and 3' are inserted and fixed into the respective 4 and 4', and the lead wires 3 and 3' and the skin surface are connected to the conductive layer 4. , 4'.

The example in Figure 2 shows conductive layers 4, 4' and adhesive sheet 1.
A flexible carrier 5 made of the same material as the support 1 is fixed between the two.

In the example shown in FIG. 3, spacers 6, 6' made of rubber and/or synthetic resin are fixed between the conductive adhesive layers 4a, 4a' and the magnetic adhesive sheet 1. The lead wires 3, 3' are sandwiched between the adhesive layers 4a, 4a'.

The conductive adhesive layers 4a, 4a' are made of a composition comprising a hydrogel adhesive substance, an adhesive substance mainly composed of rubber and/or synthetic resin, conductive powder, and, if necessary, a drug. It is,
The advantage of using such pressure sensitive adhesives is that reliable contact is maintained.

The example in FIG. 4 is the spacer 6 in FIG.
6', a pressure-sensitive adhesive layer 7 is previously formed on the entire surface or a portion of the surface of the carrier 5, and the diode main body 2 is also adhered to the adhesive layer 7. , it is something that never rises to the surface.

In the example shown in FIG. 5, conductive layers 4b and 4b' made of flexible conductive metal bodies are adhered to the upper surfaces of lead wires 3 and 3' fixed with adhesive layers 8 and 8', and Part of the adhesive layer 8, 8' is exposed H,
It is designed to be pasted on the skin.

By configuring in this way, the adhesive layer 8,
8' has both the function of fixing the lead wires 3, 3' and the conductive layers 4b, 4b' and the function of attaching them to the skin.

In the example shown in FIG. 6, conductive layers 4b and 4b' made of conductive metal bodies having the same shape as adhesive layers 8 and 8' are bonded via lead wires 3 and 3', and conductive layers 4b and 4b' are bonded together via lead wires 3 and 3'.
Adhesive layers 9, 9' are formed on part of the surfaces of b, 4b' so that they can be attached to the skin.

Note that it is preferable to temporarily attach a releasable film or something similar to the exposed adhesive layer in order to protect the surface of the layer. The therapeutic device of the present invention is
It is applied to the application surface (skin) in the same manner as conventional diode therapy devices. For example, Ido Nissatsu Tokyo Bulletin, Vol. 28, No. 4, p. 213 (1971)
Apply to the 6 points each on the upper wrist and upper ankle (these 6 points are shown in Figure 7) as described in December 2015.

As described above, the therapeutic component of the present invention is composed of a diode, a magnet, and a specific drug.
Their synergistic effect provides a remarkable treatment effect for indeterminate complaints, and since the lead wire of the diode is covered with a conductive layer, the skin will not be injured, and the conductive layer connected to the lead wire Since it is formed on the outermost surface, it has the characteristic of providing good adhesion to the skin.

[Brief explanation of the drawing]

FIG. 1A is a perspective view showing an example of the present invention, FIG. 1B is a sectional view taken along the line -' of FIG. 1A, and FIGS. 2 to 6 are sectional views showing other examples. . FIG. 7 is a diagram showing six points each on the wrist and upper ankle, which are one of the sites to which the treatment member of the present invention is applied. DESCRIPTION OF SYMBOLS 1... Magnetic adhesive sheet, 2... Diode body, 3, 3'... Lead wire, 4, 4'... Conductive layer made of a flexible conductive metal body, 4a, 4
a'... Conductive adhesive layer, 4b, 4b'... Conductive layer, 5
...Supporter, 6,6'...Spacer, 7,8,
8' and 9,9'...Adhesive layer, 11...Magnetic sheet, 12...Adhesive layer, H...Adhesive layer 7, 8,
Exposed portion of 8' or 9,9'.

Claims (1)

[Scope of utility model registration request] Approximately in the center of the magnetic adhesive sheet, directly or via a carrier, a spacer and/or an adhesive,
A conductive layer is provided leaving a gap, a diode with lead wires at both ends is installed in the gap, and the diode with lead wires at both ends is covered and fixed at the lead wire portion with the conductive layer without damaging the skin. , a member for treating indefinite complaints, comprising at least one drug selected from skin irritating drugs and analgesic and anti-inflammatory agents blended into at least the adhesive of the conductive layer and/or the magnetic adhesive sheet.